MedTrace Logo

Treatment of Insomnia in Migraineurs

NCT00812214 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 113

Last updated 2023-06-15

Study results available
· View outcomes & findings →

Summary

It is hypothesized that treating insomnia in migraineurs, many of whom also have tension headaches, prolongs total sleep time to the extent that it decreases overall headache frequency. Chronic headache sufferers also feel more tired during the day, undoubtedly affecting daytime functioning, which is hypothesized to improve as well with prolonged total sleep time.

Conditions

Interventions

DRUG

eszopiclone

3 mg tablet every night at bedtime

DRUG

placebo

1 tablet every night at bedtime

Sponsors & Collaborators

  • MedVadis Research Corporation

    lead INDUSTRY

Principal Investigators

  • Egilius LH Spierings, M.D., Ph.D. · MedVadis Research Corporation

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-04-30
Primary Completion
2008-09-30
Completion
2008-09-30

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00812214 on ClinicalTrials.gov